Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02353728
Title Stem Cell Monitoring for CML Patients Undergoing Nilotinib Therapy
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Weill Medical College of Cornell University
Indications

chronic myeloid leukemia

Therapies

Nilotinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.